|
|
| (32 intermediate revisions by one other user not shown) |
| Line 1: |
Line 1: |
| == Do's == | | ==pic== |
| '''Thyroglobulin level monitoring'''
| | {| |
| *Order serum [[thyroglobulin]] periodically during follow-up of patients with differentiated [[thyroid cancer]] who have undergone less than total [[thyroidectomy]]
| | |[[image:LowKECG.png|thumb|700px|center|An ECG in a person with a potassium level of 1.1 showing the classical ECG changes of ST segment depression, inverted T waves, large U waves, and a slightly prolonged PR interval. By James Heilman, MD - Own work, CC BY-SA 3.0]] |
| *Order serum [[thyroglobulin]] periodically during follow-up of patients with differentiated [[thyroid cancer]] who have had a total [[thyroidectomy]] but not [[Iodine-131|radioactive iodine]] ablation
| | |} |
| '''Cervical ultrasound'''
| | <br style="clear:left" /> |
| *Perform [[neck]] [[ultrasound]] to evaluate [[thyroid]] 6–12 months following surgery
| |
| '''18FDG-PET scanning'''
| |
| *Consider 18FDG-PET scanning in high-risk differentiated [[thyroid cancer]] patients with elevated serum [[thyroglobulin]] (generally >10 ng/mL) and negative [[Iodine-131|radioactive iodine]] imaging
| |
| '''CT scans'''
| |
| *Order [[chest]] [[Computed tomography|CT scan]] with or without intravenous [[Contrast medium|contrast]] in high-risk differentiated [[thyroid cancer]] patients with elevated serum [[thyroglobulin]] (generally >10 ng/mL) or rising [[thyroglobulin]] [[antibodies]] with or without negative [[Iodine-131|radioactive iodine]] imaging
| |
| '''TSH range'''
| |
| *Maintain serum [[Thyroid-stimulating hormone|TSH]] below 0.1 mU/L in patients with a structural incomplete response to therapy, indefinitely in the absence of specific contraindications
| |
| *Maintain serum [[Thyroid-stimulating hormone|TSH]] between 0.5-2 mU/L in patients with an excellent or indeterminate response to therapy, especially those at low risk for recurrence
| |
| '''Surgery for nodal disease'''
| |
| *Perform surgery in patients with clinically apparent, macroscopic nodal disease
| |
| *Perform therapeutic compartmental central and/or lateral [[neck dissection]] in a previously operated [[Compartment (anatomy)|compartment]], in patients with [[biopsy]]-proven persistent or recurrent disease for central [[neck]] nodes ≥8 mm and lateral [[neck]] nodes ≥10 mm
| |
| *Perform compartmental surgery
| |
| *Perform combination of surgery and [[Iodine-131|radioactive iodine]] and/or [[External beam radiotherapy|external beam radiation therapy]] (EBRT) in patients with aerodigestive invasive disease
| |
| *Order [[complete blood count]] and assessment of renal function before administration of [[Iodine-131|radioactive iodine]]
| |
| *Discuss preventive strategies for [[dental caries]] with patients with [[xerostomia]]
| |
|
| |
|
| '''Radioactive iodine therapy'''
| | [[image:LowKECG.png|thumb|700px|right|An ECG in a person with a potassium level of 1.1 showing the classical ECG changes of ST segment depression, inverted T waves, large U waves, and a slightly prolonged PR interval. By James Heilman, MD - Own work, CC BY-SA 3.0]] |
| *Order [[pregnancy test]] before [[Iodine-131|radioactive iodine]] administration
| | <br style="clear:left" /> |
| *Administer [[Iodine-131|radioactive iodine]] therapy in patients with iodine-avid [[bone metastases]]
| | |
| *Administer [[Iodine-131|radioactive iodine]] therapy in patients with [[Lung|pulmonary]] micrometastases and every 6-12 months | | {{#ev:youtube|7TWu0_Gklzo}} |
| | |
| | ==Table== |
| | {| |
| | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Complications |
| | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Polymyositis |
| | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dermatomyositis |
| | |- |
| | ! align="center" style="background:#DCDCDC;" + |[[Cancer|Malignancy]] |
| | | align="left" style="background:#F5F5F5;" + | |
| | *[[Lung]] |
| | | align="center" style="background:#F5F5F5;" + | |
| | *[[Lung]] |
| | |} |
